# Hydroxy Chloroquine and Covid in RA Patients

> **NCT04471649** · — · UNKNOWN · sponsor: **Tanta University** · enrollment: 80 (estimated)

## Conditions studied

- COVID

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04471649
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-15
- **Primary completion:** 2020-10
- **Final completion:** 2020-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04471649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04471649, "Hydroxy Chloroquine and Covid in RA Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04471649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*